Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilson Lam

Showing results (71-80 of 118) with videos related to

Pageof 12
Sort By:
Transplantation and Cellular Therapy|May 9, 2021
Experience Using Anti-Thymocyte Globulin With Post-Transplantation Cyclophosphamide for Graft-Versus-Host Disease Prophylaxis in Peripheral Blood Haploidentical Stem Cell TransplantationMaria Queralt Salas, Eshetu G Atenafu, Arjun Datt Law, et al.
Blood Cell Therapy|January 30, 2023
High Overall and GVHD-Free Survival in Patients with Aplastic Anemia Receiving <i>in vivo</i> T-cell Depletion Transplants and Long-Term ComplicationsMaria Queralt Salas, Eshetu G Atenafu, Wilson Lam, et al.
Bone Marrow Transplantation|February 7, 2020
Dual T-cell depletion with ATG and PTCy for peripheral blood reduced intensity conditioning allo-HSCT results in very low rates of GVHDMaria Queralt Salas, Shruti Prem, Eshetu G Atenafu, et al.
European Journal of Haematology|August 27, 2019
Reduced intensity allogeneic stem cell transplant with anti-thymocyte globulin and post-transplant cyclophosphamide in acute myeloid leukemiaMaria Queralt Salas, Shruti Prem, Eshetu G Atenafu, et al.
European Journal of Haematology|January 9, 2021
Refined hepatic grading system in chronic graft-versus-host disease improves prognostic risk stratification of long-term outcomesIgor Novitzky-Basso, Saud AlHayli, Elizabeth Shin, et al.
Bone Marrow Transplantation|June 10, 2021
Efficacy and cost analysis of eltrombopag in thrombocytopenia and poor graft function post allogeneic hematopoietic cell transplantationRam Vasudevan Nampoothiri, Lina Ho, Cassandra McEwan, et al.
Leukemia & Lymphoma|July 28, 2020
High incidence but low mortality of EBV-reactivation and PTLD after alloHCT using ATG and PTCy for GVHD prophylaxisMaria Queralt Salas, Shruti Prem, Mats Remberger, et al.
Transplantation and Cellular Therapy|October 5, 2023
Propensity Score Matching Analysis Comparing the Efficacy and Steroid Tapering Benefit of Extracorporeal Photopheresis to Best Available Therapy in Third-Line or Beyond Treatment for Chronic GvHDIgor Novitzky-Basso, Christopher Patriquin, Swe Mar Linn, et al.
Transplantation and Cellular Therapy|August 14, 2023
Choosing Between Older Matched Sibling Donor and Younger Matched Unrelated Donor in Allogeneic Hematopoietic Cell Transplantation: Comparison of Clinical Outcomes in Acute Myeloid Leukemia and Myelodysplastic SyndromeMariana Pinto Pereira, Mats Remberger, Carol Chen, et al.
Transplantation and Cellular Therapy|October 30, 2025
Herpes Zoster Frequency and Adjuvanted Recombinant Zoster Vaccination after Allogeneic Hematopoietic Cell TransplantationVictoria G Hall, Caden Chiarello, Mats Remberger, et al.
Pageof 12

Showing results (71-80 of 118) with videos related to

Sort By:
Pageof 12
Transplantation and Cellular Therapy|May 9, 2021
Experience Using Anti-Thymocyte Globulin With Post-Transplantation Cyclophosphamide for Graft-Versus-Host Disease Prophylaxis in Peripheral Blood Haploidentical Stem Cell TransplantationMaria Queralt Salas, Eshetu G Atenafu, Arjun Datt Law, et al.
Blood Cell Therapy|January 30, 2023
High Overall and GVHD-Free Survival in Patients with Aplastic Anemia Receiving <i>in vivo</i> T-cell Depletion Transplants and Long-Term ComplicationsMaria Queralt Salas, Eshetu G Atenafu, Wilson Lam, et al.
Bone Marrow Transplantation|February 7, 2020
Dual T-cell depletion with ATG and PTCy for peripheral blood reduced intensity conditioning allo-HSCT results in very low rates of GVHDMaria Queralt Salas, Shruti Prem, Eshetu G Atenafu, et al.
European Journal of Haematology|August 27, 2019
Reduced intensity allogeneic stem cell transplant with anti-thymocyte globulin and post-transplant cyclophosphamide in acute myeloid leukemiaMaria Queralt Salas, Shruti Prem, Eshetu G Atenafu, et al.
European Journal of Haematology|January 9, 2021
Refined hepatic grading system in chronic graft-versus-host disease improves prognostic risk stratification of long-term outcomesIgor Novitzky-Basso, Saud AlHayli, Elizabeth Shin, et al.
Bone Marrow Transplantation|June 10, 2021
Efficacy and cost analysis of eltrombopag in thrombocytopenia and poor graft function post allogeneic hematopoietic cell transplantationRam Vasudevan Nampoothiri, Lina Ho, Cassandra McEwan, et al.
Leukemia & Lymphoma|July 28, 2020
High incidence but low mortality of EBV-reactivation and PTLD after alloHCT using ATG and PTCy for GVHD prophylaxisMaria Queralt Salas, Shruti Prem, Mats Remberger, et al.
Transplantation and Cellular Therapy|October 5, 2023
Propensity Score Matching Analysis Comparing the Efficacy and Steroid Tapering Benefit of Extracorporeal Photopheresis to Best Available Therapy in Third-Line or Beyond Treatment for Chronic GvHDIgor Novitzky-Basso, Christopher Patriquin, Swe Mar Linn, et al.
Transplantation and Cellular Therapy|August 14, 2023
Choosing Between Older Matched Sibling Donor and Younger Matched Unrelated Donor in Allogeneic Hematopoietic Cell Transplantation: Comparison of Clinical Outcomes in Acute Myeloid Leukemia and Myelodysplastic SyndromeMariana Pinto Pereira, Mats Remberger, Carol Chen, et al.
Transplantation and Cellular Therapy|October 30, 2025
Herpes Zoster Frequency and Adjuvanted Recombinant Zoster Vaccination after Allogeneic Hematopoietic Cell TransplantationVictoria G Hall, Caden Chiarello, Mats Remberger, et al.
Pageof 12